Nutex Health Net Worth

Nutex Health Net Worth Breakdown

  NUTX
The net worth of Nutex Health is the difference between its total assets and liabilities. Nutex Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Nutex Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Nutex Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if Nutex Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Nutex Health stock.

Nutex Health Net Worth Analysis

Nutex Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Nutex Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Nutex Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Nutex Health's net worth analysis. One common approach is to calculate Nutex Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Nutex Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Nutex Health's net worth. This approach calculates the present value of Nutex Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Nutex Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Nutex Health's net worth. This involves comparing Nutex Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Nutex Health's net worth relative to its peers.

Enterprise Value

500.73 Million

To determine if Nutex Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nutex Health's net worth research are outlined below:
Nutex Health generated a negative expected return over the last 90 days
Nutex Health has high historical volatility and very poor performance
Nutex Health is unlikely to experience financial distress in the next 2 years
About 36.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Nutex Health Inc. Stock Analysis and Forecast - Massive wealth growth - Jammu Links News

Nutex Health Quarterly Good Will

13.92 Million

Nutex Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nutex Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nutex Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Nutex Health's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nutex Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nutex Health backward and forwards among themselves. Nutex Health's institutional investor refers to the entity that pools money to purchase Nutex Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Drive Wealth Management, Llc2025-03-31
23.4 K
Marshall Wace Asset Management Ltd2025-03-31
21.8 K
The Informed Momentum Company (formerly Eam Investors)2025-03-31
18.5 K
Goldman Sachs Group Inc2025-03-31
18.1 K
Ancora Advisors Llc2025-03-31
18.1 K
State Street Corp2025-03-31
14 K
H D Vest Advisory Services2025-03-31
12.3 K
Jane Street Group Llc2025-03-31
11.1 K
Qube Research & Technologies2025-03-31
10.8 K
Topline Capital Management Llc2025-03-31
179.7 K
Vanguard Group Inc2025-03-31
134.8 K
Note, although Nutex Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Nutex Health's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 632.23 M.

Market Cap

176.57 Million

Project Nutex Health's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.09 
Return On Capital Employed 0.25  0.27 
Return On Assets 0.08  0.08 
Return On Equity 0.36  0.37 
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.34 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.34.
When accessing Nutex Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Nutex Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nutex Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Nutex Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutex Health. Check Nutex Health's Beneish M Score to see the likelihood of Nutex Health's management manipulating its earnings.

Evaluate Nutex Health's management efficiency

Nutex Health has return on total asset (ROA) of 0.2234 % which means that it generated a profit of $0.2234 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.7892 %, meaning that it created $0.7892 on every $100 dollars invested by stockholders. Nutex Health's management efficiency ratios could be used to measure how well Nutex Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.09 in 2025. Return On Capital Employed is likely to rise to 0.27 in 2025. At this time, Nutex Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 381 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 462.9 K in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 39.59  41.57 
Tangible Book Value Per Share 33.81  35.50 
Enterprise Value Over EBITDA 3.08  3.24 
Price Book Value Ratio 1.10  1.16 
Enterprise Value Multiple 3.08  3.24 
Price Fair Value 1.10  1.16 
Enterprise Value527.1 M500.7 M
Understanding the operational decisions made by Nutex Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue
1.4238
Revenue
624.3 M
Quarterly Revenue Growth
2.14
Revenue Per Share
118.737
Return On Equity
0.7892
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nutex Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nutex Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nutex Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Vo Thomas T. over three weeks ago
Acquisition by Vo Thomas T. of 10000 shares of Nutex Health subject to Rule 16b-3
 
Jon Bates over three months ago
Acquisition by Jon Bates of 1000 shares of Nutex Health at 81.81 subject to Rule 16b-3
 
Hosseinion Warren over three months ago
Acquisition by Hosseinion Warren of 180000 shares of Nutex Health at 2.4836 subject to Rule 16b-3
 
Luqman Elisa V over three months ago
Disposition of 266 shares by Luqman Elisa V of Nutex Health at 72.0972 subject to Rule 16b-3
 
Premier Macy Management Holdings, Llc over three months ago
Disposition of 125498 shares by Premier Macy Management Holdings, Llc of Nutex Health at 2.2054 subject to Rule 16b-3
 
Jon Bates over three months ago
Disposition of 20000 shares by Jon Bates of Nutex Health subject to Rule 16b-3
 
Vo Thomas T. over three months ago
Acquisition by Vo Thomas T. of 114884 shares of Nutex Health at 0.48 subject to Rule 16b-3
 
Vo Thomas T. over six months ago
Acquisition by Vo Thomas T. of 5000 shares of Nutex Health subject to Rule 16b-3
 
Hosseinion Warren over six months ago
Acquisition by Hosseinion Warren of 100000 shares of Nutex Health at 2.99 subject to Rule 16b-3
 
Dogan Timur over six months ago
Acquisition by Dogan Timur of 68965 shares of Nutex Health at 0.29 subject to Rule 16b-3
 
Jon Bates over six months ago
Acquisition by Jon Bates of 1350 shares of Nutex Health at 21.4589 subject to Rule 16b-3
 
Detillio Joshua over six months ago
Acquisition by Detillio Joshua of 575 shares of Nutex Health at 17.4 subject to Rule 16b-3

Nutex Health Corporate Filings

8K
16th of July 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
27th of June 2025
Other Reports
ViewVerify
2nd of June 2025
Other Reports
ViewVerify
22nd of May 2025
Other Reports
ViewVerify
Nutex Health time-series forecasting models is one of many Nutex Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nutex Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Nutex Health Earnings per Share Projection vs Actual

Nutex Health Corporate Management

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.